| 12-Dec-13 01:24PM | Nasdaq stocks posting largest percentage increases AP +15.31% |
| 09-Dec-13 11:10AM | Sarepta's Rocky 2013 at Motley Fool |
| 06-Dec-13 07:44AM | Sarepta downgraded to Hold from from Buy at Canaccord theflyonthewall.com |
| 05-Dec-13 02:04PM | 3 Biotech Flops of 2013 at Motley Fool |
| 04-Dec-13 01:05PM | Sarepta Therapeutics' CEO Presents at Piper Jaffray 2013 Healthcare Conference (Transcript) at Seeking Alpha |
| 03-Dec-13 08:41PM | 3 Biggest FDA Decisions of 2013 at Motley Fool |
| 02-Dec-13 09:05PM | Sarepta Therapeutics' Management Presents at Deutsche Bank BioFEST Conference (Transcript) at Seeking Alpha |
| 09:05PM | Sarepta Therapeutics' CEO Presents at Deutsche Bank BioFEST Conference (Transcript) at Seeking Alpha |
| 01-Dec-13 03:15PM | November's 3 Biggest Biotech Busts at Motley Fool |
| 29-Nov-13 08:05AM | 3 Black Friday Biotech Bargains at Motley Fool +6.03% |
| 26-Nov-13 08:48AM | Sarepta Therapeutics upgraded by WBB Securities Briefing.com +7.75% |
| 25-Nov-13 12:43PM | Lion Biotechnologies: 3 Bullish Reasons Why I Like This Speculative Biotech at Seeking Alpha +5.63% |
| 19-Nov-13 04:56PM | Has This FDA Decision Created a Value Investment Opportunity? at Motley Fool |
| 08:30AM | Sarepta Therapeutics to Present Company Overview at Upcoming Conferences Marketwired |
| 17-Nov-13 10:23AM | Amarin, Sarepta And Vanda: Teachable Moments In Biotech at Seeking Alpha |
| 07:15AM | 5 of Last Week's Biggest Losers at Motley Fool |
| 16-Nov-13 01:05PM | SAREPTA THERAPEUTICS, INC. Financials EDGAR Online Financials |
| 12:49PM | This Week in Biotech at Motley Fool |
| 08:03AM | 3 Horrendous Health-Care Stocks This Week at Motley Fool |
| 12:01AM | [$$] Follow Up at Barrons.com |
| 15-Nov-13 01:30PM | Nasdaq stocks posting largest percentage increases AP |
| 09:14AM | Eteplirsen in Question: Hope for Sarepta at Motley Fool |
| 14-Nov-13 06:09PM | Nasdaq stocks posting largest percentage increases AP +11.79% |
| 03:50PM | Post-Plunge: Is Sarepta a Bad News Buy? at Motley Fool |
| 06:00AM | How to Trade Sarepta After the FDA Setback at TheStreet |
| 03:30AM | Sarepta Therapeutics: No Longer A Momentum Play, But Long-Term Value Remains at Seeking Alpha |
| 13-Nov-13 07:18PM | 3 Stocks to Get on Your Watchlist at Motley Fool |
| 04:57PM | INVESTOR ALERT: Federman & Sherwood Investigates Sarepta Therapeutics, Inc. for Possible Securities Laws Violations Business Wire |
| 02:58PM | Levi & Korsinsky, LLP Launches Investigation of SAREPTA THERAPEUTICS, INC. for Possible Violations of Federal Securities Laws PR Newswire |
| 01:20PM | Nasdaq stocks posting largest percentage decreases AP |
| 12:03PM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT PR Newswire |
| 11:10AM | Sarepta Down on FDA's Response Zacks |
| 07:57AM | Sarepta Therapeutics downgraded by Needham Briefing.com |
| 07:57AM | Sarepta Therapeutics downgraded by Needham and Deutsche Bank Briefing.com |
| 06:47AM | A Post-Mortem on Sarepta's Epic Explosion, Mea Culpa Included at TheStreet |
| 12-Nov-13 09:04PM | Why Sarepta Therapeutics, Amedisys, and Hanwha SolarOne Dropped With the Dow Today at Motley Fool -64.00% |
| 06:31PM | Bad News Buy? You Bet! at Motley Fool |
| 06:19PM | Nasdaq stocks posting largest percentage decreases AP |
| 06:19PM | US STOCKS-Wall St dips after 2-day rise; eyes on Fed's taper timing Reuters |
| 04:23PM | [$$] FDA Wants More Testing of Muscular-Dystrophy Drug at The Wall Street Journal |
| 03:07PM | What The Delay Of A Promising Muscular Dystrophy Drug Means For Patients, Investors And All Of Biotech at Forbes |
| 03:00PM | Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sarepta Therapeutics, Inc. PR Newswire |
| 02:45PM | Sarepta Therapeutics' CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 02:20PM | Sarepta Therapeutics Plunges On Negative FDA Report at Investor's Business Daily |
| 01:30PM | Sarepta Shares Slammed in FDA Smackdown at Motley Fool |
| 01:29PM | Analysts: Macys Estimates Are Overly Optimistic and 3 More Research Notes to Look Through at Wall St. Cheat Sheet |
| 01:24PM | Nasdaq stocks posting largest percentage decreases AP |
| 12:57PM | [$$] FDA Wants More Testing of Muscular-Dystrophy Drug at The Wall Street Journal |
| 12:35PM | On The Fly: Midday Wrap at theflyonthewall.com |
| 11:57AM | Sarepta downgraded to Hold from Buy at Needham theflyonthewall.com |
| 11:56AM | GlaxoSmithKline Drug Falls Short, Sarepta Shares Collapse, and 3 More Hot Stocks at Wall St. Cheat Sheet |
| 11:23AM | Sarepta plunges after company update on eteplirsen AP |
| 10:42AM | Why Sarepta Therapeutics Inc. Shares Got Slaughtered at Motley Fool |
| 10:25AM | Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen (Updated) at TheStreet |
| 09:34AM | Stocks to Watch: Sarepta, Dish , NRG at The Wall Street Journal |
| 09:23AM | [video] Cramer's Mad Dash: Sarepta is 'Russian roulette' at CNBC |
| 09:16AM | Why You Should Be Watching Sarepta, Hologic, and Achillion Today at Motley Fool |
| 09:04AM | [$$] Sarepta: FDA Wants More Testing of Muscular Disease Drug at The Wall Street Journal |
| 08:05AM | Sarepta downgraded to Underweight from Overweight at Piper Jaffray theflyonthewall.com |
| 08:00AM | Sarepta Falls as FDA Calls Drug Application Premature at Bloomberg |
| 08:00AM | Sarepta Therapeutics Inc Earnings Call scheduled for 8:00 am ET today CCBN |
| 07:55AM | Sarepta Therapeutics, Inc. Discusses Q3 2013 Results (Webcast) at Seeking Alpha |
| 07:30AM | Vanda stages huge rally on FDA news optionMONSTER |
| 07:25AM | Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen at TheStreet |
| 07:10AM | SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosur EDGAR Online |
| 07:08AM | InPlay: Sarepta Therapeutics announces FDA considers NDA filing for eteplirsen premature in light of recent competitive drug failure and recent DMD natural history data; FDA questions dystrophin as a biomarker due to failed studies of other Briefing.com |
| 07:07AM | Q3 2013 Sarepta Therapeutics Inc Earnings Release - Before Market Open CCBN |
| 07:02AM | SAREPTA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:00AM | Sarepta Therapeutics Announces Third Quarter 2013 Financial Results and Recent Corporate Developments Marketwired |
| 06:55AM | Sarepta Therapeutics Announces FDA Considers NDA Filing for Eteplirsen Premature in Light of Recent Competitive Drug Failure and Recent DMD Natural History Data Marketwired |
| 06-Nov-13 04:32PM | SRPT Makes Notable Cross Below Critical Moving Average at Forbes |
| 06:06AM | A Rebuttal Of The Sarepta Bull Rebuttal at Seeking Alpha |
| 04-Nov-13 10:06AM | Why I'm More Confident in Sarepta Than Ever Before at TheStreet |
| 09:16AM | 3 Promising Biotech Stocks with Upcoming Catalysts at Wall St. Cheat Sheet |
| 08:58AM | 3 Promising Biotech Stocks with Upcoming Catalysts at Wall St. Cheat Sheet |
| 07:07AM | Q3 2013 Sarepta Therapeutics Inc Earnings Release - Before Market Open CCBN |
| 31-Oct-13 06:00AM | A Rousing Rebuttal of the Sarepta Serial Short at TheStreet |
| 30-Oct-13 11:12AM | Sarepta Therapeutics: Underappreciated Clinical And Regulatory Risk Following Analysis Of Prosensa Failure at Seeking Alpha -7.78% |
| 07:00AM | Short Sarepta: DMD Drug Prognosis Is Dismal at Seeking Alpha |
| 29-Oct-13 10:52PM | Coverage initiated on Sarepta Therapeutics by FBR Capital Briefing.com |
| 25-Oct-13 06:00AM | Biotech Stock Mailbag: Vanda, Onconova, Catalyst Pharma, Sarepta at TheStreet |
| 24-Oct-13 08:30AM | Sarepta Therapeutics to Announce Third Quarter 2013 Financial Results and Corporate Update on November 12, 2013 Marketwired |
| 23-Oct-13 12:18PM | Watch This Mother Fight To Get Her Kids A Medicine She Thinks Could Save Their Lives at Forbes |
| 21-Oct-13 03:44PM | Sarepta On The Move at Seeking Alpha |
| 19-Oct-13 05:54PM | Top 5 Biotech Tweets of the Week at Motley Fool |
| 17-Oct-13 04:01PM | Sarepta Therapeutics' CEO Hosts Sarepta DMD Development Program Update (Transcript) at Seeking Alpha |
| 12:00PM | Walmart de Mxico y Centroamrica Earnings Call scheduled for 12:00 pm ET today CCBN |
| 12:00PM | Sarepta DMD Development Program Update Call scheduled for 12:00 pm ET today CCBN |
| 12:00PM | Orbital Sciences Corporation Earnings Call scheduled for 12:00 pm ET today CCBN |
| 12:00PM | Harmonic Earnings Call scheduled for 12:00 pm ET today CCBN |
| 08:30AM | Parent Project Muscular Dystrophy and Sarepta Therapeutics Join Forces on Genetic Testing Program for Patients With Duchenne Muscular Dystrophy Marketwired |
| 07:34AM | Sarepta DMD Development Program Update Call scheduled for 12:00 pm ET today CCBN |
| 15-Oct-13 08:00AM | Our Best Small-Cap Biotech Picks For The Rest Of This Year at Seeking Alpha |
| 12-Oct-13 11:10AM | Sarepta Drops -- Is There Reason to Sell? at Motley Fool |
| 11-Oct-13 07:55AM | InPlay: Sarepta Therapeutics to host webcast and conference call for the Duchenne Muscular Dystrophy Community on October 17 at 12pm ET Briefing.com |
| 10-Oct-13 04:30PM | Sarepta Therapeutics to Host Webcast and Conference Call for the Duchenne Muscular Dystrophy Community on October 17, 2013 Marketwired +6.21% |
| 09:47AM | Trade-Ideas: Sarepta Therapeutics (SRPT) Is Today's "Dead Cat Bounce" Stock at TheStreet |
| 09-Oct-13 07:34PM | Bloodbath Signals Biotech Bubble Bursting? at Motley Fool -11.25% |
| 04:28PM | Sticker Shock: Will Orphan Drug Reimbursement Remain Stable? at Forbes |
| 08-Oct-13 05:38PM | Finding Very Valuable Patients at Motley Fool -6.99% |
